Valproic Acid, a Histone Deacetylase Inhibitor, Induces Apoptosis, Inhibits Proliferation, and Synergizes With Chemotherapy: The Rationale to Combine it for the Treatment of B-Cell Chronic Lymphocytic Leukemia
Clinical Lymphoma and Myeloma · 2009-12 · 9 (6) · E38
DOI: 10.3816/clm.2009.n.100 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Lymphoma and Myeloma, 2009-12. Verfasst von Basile Stamatopoulos und 4 weiteren Autor:innen.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Stamatopoulos, B., Lagneaux, L., Bruyn, C. D., Mineur, P., & Willems, L. (2009). Valproic Acid, a Histone Deacetylase Inhibitor, Induces Apoptosis, Inhibits Proliferation, and Synergizes With Chemotherapy: The Rationale to Combine it for the Treatment of B-Cell Chronic Lymphocytic Leukemia. Clinical Lymphoma and Myeloma, 9(6), E38. https://doi.org/10.3816/clm.2009.n.100
Vancouver
Stamatopoulos B, Lagneaux L, Bruyn CD, Mineur P, Willems L. Valproic Acid, a Histone Deacetylase Inhibitor, Induces Apoptosis, Inhibits Proliferation, and Synergizes With Chemotherapy: The Rationale to Combine it for the Treatment of B-Cell Chronic Lymphocytic Leukemia. Clinical Lymphoma and Myeloma. 2009;9(6):E38. doi:10.3816/clm.2009.n.100
BibTeX
@article{Stamatopoulos2009,
author = {Stamatopoulos, Basile and Lagneaux, L. and Bruyn, C. De and Mineur, P. and Willems, L.},
title = {Valproic Acid, a Histone Deacetylase Inhibitor, Induces Apoptosis, Inhibits Proliferation, and Synergizes With Chemotherapy: The Rationale to Combine it for the Treatment of B-Cell Chronic Lymphocytic Leukemia},
journal = {Clinical Lymphoma and Myeloma},
year = {2009},
volume = {9},
number = {6},
pages = {E38},
doi = {10.3816/clm.2009.n.100}
}
EUVIMED